Jonathan Peachey Joins PhESi as Head of Client Services
PhESi has announced the appointment of Jonathan Peachey as a member of the Board and Head of Client Services today.
Peachey has an outstanding track record of growing successful businesses in the life sciences industry, most recently as a Board Director and Head of Client Partnerships at Kinapse Ltd. Peachey has 25 years of industry experience, leading and delivering business transformation across Pharma R&D. His capabilities span strategy, business and IT transformation and performance improvement. Previously, Peachey has led IBM's EU Pharma R&D consulting practice and has held roles at GSK, BMS and Pfizer.
Breakthrough in Forecasting Enrollment Rate
In a recently published article Forecasting enrollment rate in clinical trials in APPLIED CLINICAL TRIALS online, Gen Li, President of PhESi, revealed that clinical trial enrollment rates can be expressed by simple mathematical formulas. For the first time, we can accurately forecast enrollment rate in clinical trials, and shorten
enrollment cycle time through proactively designed actions.
Michael Tansey Joins PhESi
Michael Tansey, BSC MB ChB MD FFPM, former Chief Medical Officer of Pharmacia Corporation, has joined PhESi as a strategic partner.
Dr. Tansey is an established visionary leader in the pharmaceutical industry, with extensive international line management, strategic oversight, project development and process redesign experience.
Joining forces between Dr. Tansey and PhESi will further enhance and expand our ability to serve our clients.